Get the tools used by (smart)2 investors.

3 Month Price Total Return

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

-
Price
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's 3 Month Price Total Return:

  • Eli Lilly's common equity last quarter was 14.192 billion
  • Eli Lilly's common equity for fiscal years ending December 2020 to 2024 averaged 10.047 billion.
  • Eli Lilly's operated at median common equity of 10.65 billion from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Eli Lilly's common equity peaked in December 2024 at 14.192 billion.
  • Eli Lilly's common equity hit its 5-year low in December 2020 of 5.642 billion.
  • Eli Lilly's common equity increased in each of the last 5 fiscal years from 5.642 billion in 2020 to 14.192 billion in 2024.

Benchmarks

Hide this widget

No data available

Metric Usage

Hide this widget

No data available

Similar Metrics

Hide this widget

No data available

Search for metric or datapoint

Definition of 3 Month Price Total Return

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget

No data available

All rights reserved. Terms Of Use